#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Craniocerebral injury Human papilloma virus immunisation Antiphospholipid syndrome Retinitis pigmentosa Cushing's syndrome Duchenne muscular dystrophy gene carrier Thrombocytosis Gastrointestinal stromal tumour Chronic graft versus host disease in intestine Allogenic stem cell transplantation Carcinoid syndrome Transferrin decreased Idiopathic inflammatory myopathy Anaplastic large cell lymphoma T- and null-cell types Inclusion body myositis More trials…

    Learn about Rare Diseases

    IgA nephropathy – Basic Information Synovial sarcoma recurrent – Diagnostics Aicardi-Goutieres syndrome – Trials in Disease Lymphatic malformation – Diagnostics Krabbe’s disease – Basic Information Breast angiosarcoma – Life with Disease Wolfram syndrome – Diagnostics Von Willebrand’s disease Pulmonary fibrosis – Diagnostics Mantle cell lymphoma stage III – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GRAPHITE Ponesimod Clofazimine L-Ascorbic Acid OXYBUTYNIN HYDROCHLORIDE Riluzole Itraconazole A49 Bgb-15025 Citrate Acetylsalicylic Acid Ph. Eur. Cimetidine Hydrochloride Tegoprubart Immunoglobulin M Acp-017 NALMEFENE HYDROCHLORIDE Alizapride Pancreas Powder Sym023 Festuca Elatior Pollen Extract Serine More therapies…

    Learn about Your Condition

    Exfoliation glaucoma Strongyloidiasis Adenomatous polyposis coli Peripheral ischaemia Myeloproliferative neoplasm Aicardi-Goutieres syndrome Anaemia of chronic disease Adrenal insufficiency Embolic stroke Tachypnoea Alport's syndrome Neurofibromatosis Ulcerative keratitis Ehlers-Danlos syndrome Lymphangioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello…

Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello

Via Trabucco 180, Palermo, 90146, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Obefazimod
    Belgium France Germany Italy Poland Spain

  • Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Obefazimod
    Belgium France Germany Italy Poland Spain

  • Study on Durvalumab with Chemotherapy for Patients with Advanced Biliary Tract Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Biliary tract disorder
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Durvalumab
    France Germany Italy Spain

  • A study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Vixarelimab
    • Adalimumab
    • Azathioprine
    Belgium Czechia France Germany Greece Italy +1

  • Evaluation of the Efficacy, Safety, and Tolerability of Subcutaneous REGN7999 in Adults with Iron Overload Due to Non-Transfusion Dependent Beta-Thalassemia

    Not recruiting

    2 1
    Investigated Drugs:
    • REGN7999
    Greece Italy

  • Study Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic graft versus host disease
    Investigated Drugs:
    • Axatilimab
    Austria Belgium Czechia Finland France Germany +8

  • Study for Adults with Chronic Myeloid Leukemia Using Asciminib Alone or with Nilotinib

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Nilotinib
    • Asciminib Hydrochloride
    Italy Spain

  • Study on the Safety and Effectiveness of CSL889 for Adults and Adolescents with Sickle Cell Disease During Painful Crises

    Not recruiting

    4 1
    Investigated Diseases:
    • Sickle cell anaemia with crisis
    Investigated Drugs:
    • HEMOPEXIN, HUMAN
    Belgium France Germany Greece Italy The Netherlands +1

  • Study on the Effectiveness and Safety of Sonrotoclax and Zanubrutinib for Adults with Untreated Chronic Lymphocytic Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • Zanubrutinib
    Italy Poland Spain

  • Study of Ruxolitinib with Brentuximab or Pembrolizumab for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hodgkin’s disease recurrent
    • Hodgkin’s disease refractory
    Investigated Drugs:
    • Brentuximab Vedotin
    • Pembrolizumab
    • Ruxolitinib
    Italy
Previous Page
1 … 3 4 5 6 7 … 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!